qSOFA and SOFA score in sepsis (also searched with alternate eponym spelling sequential organ failure assessment; quick SOFA score, ICD-10: A41.9) comprise validated clinical instruments designed to quantify the severity of acute physiological derangements and organ dysfunction in infected patients1,2. Sepsis is defined pathobiologically as a life-threatening organ dysfunction driven by a dysregulated host immune response to an underlying pathogen1,2. The Sequential Organ Failure Assessment (SOFA) score tracks six distinct organ systems—respiratory, cardiovascular, hepatic, coagulation, renal, and neurological—utilizing laboratory parameters and physiological variables to evaluate disease severity and monitor intensive care unit trajectories3,4. Conversely, the quick SOFA (qSOFA) score serves as a rapid, bedside screening tool applicable outside the intensive care unit environment, utilizing three clinical criteria without requiring immediate laboratory turnaround: altered mental status, tachypnea (respiratory rate $\ge 22/\text{min}$), and hypotension (systolic blood pressure $\le 100\text{ mmHg}$)1,4. Integration of these scoring systems standardizes clinical communication, facilitates early risk stratification, and guides targeted therapeutic interventions to reduce sepsis-associated mortality3,4.

Etiology & Risk Factors

  • Common Infectious Sources: Pulmonary infections (pneumonia), urinary tract infections, intra-abdominal infections (peritonitis, cholangitis), skin and soft tissue infections (cellulitis, necrotizing fasciitis), and central line-associated bloodstream infections1,2.
  • Microbiological Spectrum: Encompasses both Gram-negative bacilli (e.g., Escherichia coli, Klebsiella species, Pseudomonas aeruginosa) and Gram-positive cocci (e.g., Staphylococcus aureus, Streptococcus pneumoniae, enterococci), alongside fungal and viral pathogens in immunocompromised hosts3,4.
  • Host Risk Factors: Advanced age (greater than 65 years), chronic comorbidities (cirrhosis, chronic kidney disease, diabetes mellitus, chronic obstructive pulmonary disease), immunosuppressive states (malignancy, chemotherapy, solid organ transplantation, asplenia), and indwelling medical devices or catheters1,2.
  • Cirrhosis and Sepsis Vulnerability: Patients with underlying liver cirrhosis exhibit a fourfold higher sepsis-related mortality rate due to baseline immune dysfunction, portosystemic shunting, impaired complement synthesis, and diminished phagocytic clearance1.

Pathophysiology

The pathophysiological cascade of sepsis originates from pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) interacting with pattern recognition receptors (PRRs) on host immune cells. This interaction incites a massive release of pro-inflammatory cytokines, chemokines, and inflammatory mediators—frequently termed a cytokine storm. The systemic inflammatory response precipitates widespread endothelial injury, upregulating expression of adhesion molecules and tissue factor while compromising vascular barrier integrity. Consequently, profound capillary leak occurs, resulting in third-spacing of intravascular fluids, systemic vasodilation, and relative hypovolemia. Microcirculatory dysfunction ensues via leukocyte-endothelial adhesion, microvascular thrombosis, and loss of vasomotor tone, impairing oxygen extraction at the cellular level. This progressive tissue hypoxia shifts cellular metabolism toward anaerobic pathways, culminating in cellular energy depletion, intracellular acidosis, and multi-organ dysfunction syndrome (MODS) affecting the lungs, kidneys, liver, brain, and coagulation pathways, which are systematically captured by escalating SOFA scores1,3,4.

qSOFA and SOFA score in sepsis — Pathophysiological Cascade & Clinical Flowchart 1 Infection / Pathogen Invasion Localized microbial proliferation triggers an overwhelming immune response 2 Systemic Inflammatory Cascade Release of proinflammatory cytokines causes vasodilation and endothelial injury 3 Microcirculatory Failure Capillary leak, tissue hypoperfusion, and cellular hypoxia lead to metabolic acidosis 4 Multi-Organ Dysfunction Progressive decline in hepatic, renal, pulmonary, and neurological function reflected on SOFA scoring 5 Refractory Shock & Death Goal-directed resuscitation, vasopressors, and antimicrobials target tissue perfusion and microbial eradication

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically present with subjective fevers or chills, rigors, generalized fatigue, malaise, confusion, altered mental status, tachypnea, shortness of breath, oliguria, or localized pain corresponding to the primary site of infection1,4.
  • Physical Examination & Named Clinical Signs: Examination reveals hyperthermia or hypothermia (temperature $> 38.3^\circ\text{C} or < 36.0^\circ\text{C}$), tachycardia (heart rate $> 90\text{ beats/min}$), tachypnea (respiratory rate $\ge 22\text{ breaths/min}$), and hypotension (systolic blood pressure $< 90\text{ mmHg} or mean arterial pressure < 65\text{ mmHg}$ refractory to initial fluid challenge). Skin manifestations may include warm, flushed extremities in early distributive shock transitioning to cool, clammy, mottled skin with prolonged capillary refill time as tissue perfusion deteriorates. Altered mental status manifests as lethargy, encephalopathy, disorientation, or agitation1,2,4.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationSerial Sequential Organ Failure Assessment (SOFA) scoring combined with blood cultures (at least two sets: one percutaneous and one through each vascular access device in place $> 48\text{ hours}$) isolating the causative pathogen.
Laboratory PanelComplete blood count demonstrating leukocytosis ($\ge 12,000/\mu\text{L}$), leukopenia ($< 4,000/\mu\text{L}$), or bandemia ($> 10\%$ immature forms). Elevated serum lactate ($> 2.0\text{ mmol/L}$) reflecting tissue hypoperfusion and anaerobic metabolism. Coagulation profile showing thrombocytopenia (platelets $< 100 \times 10^3/\mu\text{L}$) and elevated international normalized ratio (INR). Biochemical panel revealing acute kidney injury with rising serum creatinine ($> 2.0\text{ mg/dL}$) and oliguria, alongside hyperbilirubinemia ($> 2.0\text{ mg/dL}$) reflecting hepatic dysfunction.
Imaging / Radiology (X-ray, US, CT, MRI)Chest radiography or computed tomography (CT) demonstrating focal consolidations or bilateral interstitial infiltrates suggestive of pneumonia or acute respiratory distress syndrome (ARDS). Abdominal ultrasound or CT revealing hepatobiliary pathology (e.g., acute cholecystitis, cholangitis, abscesses) or nephrolithiasis with obstructive uropathy.
ECG / Histopathology / ProceduralElectrocardiogram showing sinus tachycardia, non-specific ST-T wave changes secondary to myocardial ischemia, or new arrhythmias such as atrial fibrillation. Urinalysis and urine microscopy demonstrating pyuria, bacteriuria, or casts.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
qSOFA Score CriteriaEvaluates three bedside parameters (1 point each, maximum score of 3): 1) Respiratory rate $\ge 22\text{ breaths/min}$, 2) Altered mentation (Glasgow Coma Scale < 15), 3) Systolic blood pressure $\le 100\text{ mmHg}$. A score $\ge 2$ indicates high risk of poor clinical outcomes and prompts immediate escalation of care and formal SOFA evaluation1.
SOFA Score: Respiration (PaO2/FiO2)Evaluates gas exchange: > 400 (0 points); $\le 400$ with respiratory support (1 point); $\le 300$ (2 points); $\le 200$ with mechanical ventilation (3 points); $\le 100$ with mechanical ventilation (4 points)3,4.
SOFA Score: Coagulation & LiverPlatelets ($10^3/\mu\text{L}$): > 150 (0 points); $\le 150$ (1 point); $\le 100$ (2 points); $\le 50$ (3 points); $\le 20$ (4 points). Bilirubin ($\text{mg/dL}$): $< 1.2$ (0 points); $1.2\text{--}1.9$ (1 point); $2.0\text{--}5.9$ (2 points); $6.0\text{--}11.9$ (3 points); $> 12.0$ (4 points)3,4.
SOFA Score: Cardiovascular & CNSCardiovascular: Mean arterial pressure (MAP) $\ge 70\text{ mmHg}$ (0 points); MAP $< 70\text{ mmHg}$ (1 point); dopamine $\le 5$ or dobutamine any dose (2 points); dopamine > 5 or norepinephrine $\le 0.1$ (3 points); dopamine > 15 or norepinephrine $> 0.1 \mu\text{g/kg/min}$ (4 points). Glasgow Coma Scale: 15 (0 points); 13–14 (1 point); 10–12 (2 points); 6–9 (3 points); < 6 (4 points)3,4.
SOFA Score: Renal (Creatinine / Urine Output)Creatinine ($\text{mg/dL}$) or Urine Output: $< 1.2$ (0 points); $1.2\text{--}1.9$ (1 point); $2.0\text{--}3.4$ (2 points); $3.5\text{--}4.9 or urine output < 500\text{ mL/day}$ (3 points); $> 5.0 or urine output < 200\text{ mL/day}$ (4 points)3,4. An acute increase in total SOFA score $\ge 2$ points from baseline signifies sepsis-induced organ dysfunction1,3.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Systemic Inflammatory Response Syndrome (SIRS)Characterized by systemic inflammation from non-infectious insults (e.g., major trauma, pancreatitis, burns, post-cardiac arrest syndrome) meeting vital sign criteria without underlying microbial infection.
Cardiogenic ShockPresents with hypotension and tissue hypoperfusion driven by primary pump failure (e.g., massive myocardial infarction, acute heart failure exacerbation), typically demonstrating elevated filling pressures (pulmonary capillary wedge pressure), JVD, and pulmonary edema without primary infection.
Hypovolemic ShockMarked by hypotension and tachycardia resulting from profound intravascular volume loss (e.g., acute hemorrhage, severe dehydration, massive diuresis), responding readily to fluid resuscitation and lacking systemic inflammatory markers or infectious foci.
Anaphylactic ShockAcute, life-threatening IgE-mediated hypersensitivity reaction presenting with sudden bronchospasm, urticaria, angioedema, and distributive hypotension, resolving rapidly with intramuscular epinephrine and antihistamines.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Initiate the sepsis resuscitation bundle within the first hour of recognition. Administer an immediate intravenous crystalloid fluid bolus of $30\text{ mL/kg} for hypotension or lactate \ge 4.0\text{ mmol/L}$, utilizing balanced crystalloids (e.g., Lactated Ringer's) over normal saline to prevent hyperchloremic metabolic acidosis.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Obtain blood cultures prior to antimicrobial administration, then immediately infuse empiric broad-spectrum intravenous antimicrobials targeting likely Gram-negative, Gram-positive, and fungal pathogens within 1 hour. For community-acquired sepsis, standard regimens include IV piperacillin-tazobactam ($4.5\text{ g}$ IV every 6 hours) or cefepime ($2\text{ g}$ IV every 8 hours), combined with vancomycin ($15\text{--}20\text{ mg/kg}$ IV every 8–12 hours, targeting trough levels of $15\text{--}20\text{ mcg/mL}$) if methicillin-resistant Staphylococcus aureus is suspected. If fluid resuscitation fails to maintain a mean arterial pressure $\ge 65\text{ mmHg}$, initiate first-line vasoactive support with continuous infusion norepinephrine starting at $0.02\text{--}0.05\text{ }\mu\text{g/kg/min} titrated up to 0.5\text{ }\mu\text{g/kg/min}$ to maintain perfusion pressure, adding vasopressin at a fixed rate of $0.03\text{ units/min}$ as a second-line agent. Administer intravenous hydrocortisone ($200\text{ mg/day} given as 50\text{ mg}$ IV every 6 hours or continuous infusion) in patients with septic shock refractory to fluid and moderate-dose vasopressor therapy.
  • Surgical / Interventional Indications: Urgent source control interventions—including surgical drainage of intra-abdominal abscesses, debridement of infected necrotic tissue or necrotizing soft tissue infections, removal of infected indwelling central venous catheters or urinary prostheses, and relief of biliary or urinary tract obstruction via percutaneous drains or endoscopic retrograde cholangiopancreatography (ERCP)—must be performed as soon as anatomically feasible.

Complications & Prognosis

  • Acute Complications: Progression to refractory septic shock, acute respiratory distress syndrome (ARDS), acute kidney injury requiring continuous renal replacement therapy (CRRT), disseminated intravascular coagulation (DIC), stress-induced cardiomyopathy, paralytic ileus, and acute liver failure1,2,3.
  • Long-Term Sequelae & Prognosis: Post-sepsis syndrome encompasses cognitive impairment, functional disability, neuromuscular weakness (critical illness myopathy/neuropathy), and heightened long-term cardiovascular and mortality risks. Overall hospital mortality for severe sepsis approaches $30\%$, rising significantly with higher SOFA scores, advanced age, underlying cirrhosis, and delayed antimicrobial administration2,3,4.